Eli Lilly on Thursday said its blockbuster diabetes drug Mounjaro showed heart health benefits in a late-stage trial directly comparing it to the company's older diabetes treatment, Trulicity.
A phase 3 trial of Eli Lilly's Mounjaro versus Trulicity has achieved its primary endpoint, showing Mounjaro's noninferiority in reducing cardiovascular risks in patients with Type 2 diabetes and ...
Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...
Older female adult smiling while purchasing some medication after asking does Medicare cover Trulicity Doctors may prescribe drugs like Trulicity to help manage a person’s diabetes, but only certain ...